The SCRM platform was founded in November 2012 with the aim of facilitating new ideas and skills in translational stem cell research and cell-based therapies to flow seamlessly through the member groups.
In 2018, the the SCRM platform launched the "Translational and Clinical Bio-Manufacturing (TCBM)" initiative that was affiliated with NTN biotechnet. The main objective of TCBM was to foster exchange and collaborations between academic groups using and operating cleanrooms including bio-manufacturing products for translational clinical trials and/or standard therapies. The goal was to bundle the existing knowledge of experts in the area of compliant bio-manufacturing in order to optimise production processes (e.g. under "Good Manufacturing Practice" (GMP), ISO and/or FACT-JACIE) within an academic setting.
TCBM included the following five academic groups from all seven Swiss universities, from university hospitals and from the Swiss Federal Institute of Technology in Zurich: